General Pulmonology Track (August 7, 2014) Ballroom a & B

Total Page:16

File Type:pdf, Size:1020Kb

General Pulmonology Track (August 7, 2014) Ballroom a & B PCCP MIDYEAR CONVENTION August 7, 2014, Crowne Plaza Ballroom A&B General Pulmonology Track (August 7, 2014) Ballroom A & B Time Topic Topic 9:00- Spirometry, Lung volumes, DLCO, Ventilator waveforms 9:45 airway resistance, MVV interpretation interpretation John Clifford E. Aranas, MD, FPCCP Celeste Mae L. Campomanes, MD, FPCCP 9:45- CPET interpretation Non-invasive ventilation trouble shooting 10:30 May N. Agno, MD, FPCCP Newell R. Nacpil, MD, FPCCP 10:30- Perioperative Pulmonary Evaluation for Sleep Study interpretation 11:15 Virginia S. delos Reyes, MD, FPCCP Lung Resection Vincent M. Balanag, Jr., MD, FPCCP 11:15- Perioperative Management for Non-thoracic Imaging in Pulmonary Medicine 12:00 Joseph Leonardo Z. Obusan, MD, FPCR Surgery Abundio A. Balgos, MD, FPCCP 12:00- Luncheon Symposium Luncheon Symposium 1:30 1:30- Ventilator waveforms Spirometry, Lung volumes, DLCO, airway 2:15 interpretation resistance, MVV interpretation Albert L. Rafanan, MD, FPCCP Rachel Lee-Chua, MD, FPCCP 2:15- Non-invasive ventilation trouble CPET interpretation 3:00 shooting Josephine Blanco-Ramos, MD, FPCCP Jubert P. Benedicto, MD, FPCCP 3:00- Perioperative Pulmonary Evaluation Sleep Study interpretation 3:45 for Lung Resection Aileen Guzman-Banzon, MD, FPCCP Benilda B. Galvez, MD, FPCCP 3:45- Perioperative Management for Non- Imaging in Pulmonary Medicine 4:30 thoracic Surgery Maria Lourdes S. Badion, MD, FPCR Eileen G. Aniceto, MD, FPCCP LEARNING OBJECTIVES Spirometry, Lung volumes, DLCO, airway resistance, MVV interpretation 1. Specify the indications for pulmonary function testing. 2. Describe how the following pulmonary function tests are performed a. Spirometry i. lung volumes ii. DLCO iii. airway resistance iv. MVV 3. Understand interpretation and clinical implications of pulmonary function testing results, including differential diagnosis CPET interpretation 1. Describe the exercise physiology and principles behind the CPET 2. List the indications and contraindication of CPET 3. Describe the practical way of conducting the test 4. Interpret results relevant to pulmonary practice including use in preoperative assessment. Sleep Study interpretation 1. Discuss the preparation of patient and equipment for sleep monitoring 2. Recognize sleep stage and abnormal events recorded on the polysomnogram 3. Discuss positive pressure treatment of sleep related breathing disorders 4. Interpret polysomnogram reports Imaging in Pulmonary Medicine 1. describe the basic principles and concepts of computed tomography, CT-angiography, PET scan and lung perfusion scan 2. List the indications and contraindication/limitations of various imaging techniques 3. Correlate imaging to normal anatomy and pathology 4. Interpret lung imaging results in representative clinical cases. Ventilator waveforms Interpretation 1. Identify components of ventilator waveforms. 2. Recognize abnormal scalar and loop waveforms and clinical significance. 3. Apply knowledge of ventilator waveform interpretation to optimize ventilator management. Non-invasive ventilation trouble shooting 1. Demonstrate an understanding of the principles of non-invasive ventilation and discuss application of theory to practice. 2. State the suggested initial settings for non-invasive mechanical ventilation. 3. Properly monitor the ventilator/patient interface to include setting/troubleshooting for alarms and clinical parameters Perioperative Pulmonary Evaluation for Lung Resection 1. Evaluate patients for thoracic surgery with regard to risk factors, candidacy for surgical resection, pulmonary function studies, and possible postoperative disability. 2. Identify patients at increased risk for complications after lung resection 3. Demonstrate the usefulness of predicted postoperative FEV1 as a marker of risk for adverse outcomes. 4. Predict postoperative pulmonary function by a technique of simple calculation and use of lung perfusion scan Perioperative Management for Non-cardiothoracic Surgery 1. Discuss predictors of peri-operative pulmonary risk before non-cardiothoracic surgery 2. Discuss strategies to reduce the perioperative pulmonary risk (ex atelectasis, pneumonia, and respiratory failure). 3. Given clinical cases, formulate risk stratification evaluation and give perioperative recommendations .
Recommended publications
  • Interventional Pulmonology: a New Medical Specialty Tiberiu R
    IMAJ • VOL 16 • June 2014 REVIEWS Interventional Pulmonology: A New Medical Specialty Tiberiu R. Shulimzon MD Department of Interventional Pulmonology, Pulmonary Institute, Sheba Medical Center, Tel Hashomer, Israel (ultrasound) and invasive methods (medical thoracoscopy, tun- ABSTRACT: Interventional pulmonology (IP) is the newest chapter in neled pleural catheters). IP is now reaching the field of cellular respiratory medicine. IP includes both diagnostic and thera- and molecular biology. Different markers of micro- and nano- peutic methods. Nanotechnology, in both instrumental engin- dimensions are being developed together with optical visual eering and optical imaging, will further advance this com- technologies with the purpose of studying the cellular changes petitive discipline towards cell diagnosis and therapy as part of of inflammation and malignancy. This review will focus on the future’s personalized medicine. some of the latest developments in diagnostic and therapeutic IMAJ 2014; 16: 379–384 interventional pulmonology. KEY WORDS: interventional pulmonology (IP), confocal laser endomicroscopy (CLE), optical coherence tomography (OCT), bronchial thermoplasty (BT), bronchoscopic lung DIAGNOSTIC INTERVENTIONAL PULMONOLOGY volume reduction (BLVR) Most of the advances in diagnostic IP involved image acqui- sition and sampling instruments at bronchoscopy. However, some of the new imaging techniques reach the alveoli (alveos- copy) and the pleural cavity (pleuroscopy). t is estimated that chronic respiratory diseases cause IMAGE
    [Show full text]
  • UNC Health Care Clinic-Based Ambulatory Care Pharmacy Internship Internship Director: Ellina K
    UNC Health Care Clinic-Based Ambulatory Care Pharmacy Internship Internship Director: Ellina K. Max, PharmD, BCACP, CPP; [email protected] OVERVIEW OF INTERNSHIP The UNC Clinic-Based Ambulatory Care Pharmacy Internship is a two-year experience that combines concentrated summer programs with requirements during the academic year. It is aimed at providing future pharmacy leaders with exposure to the complexities of ambulatory care practice sites and the role of a Clinical Pharmacist Practitioner (CPP) in a unique clinic setting. The student intern will be exposed to a broad range of services and programs, with a focus in a specific therapeutic area, sharing in the goal to maintain UNC Medical Center’s Department of Pharmacy mission to provide patient-centered medication management that optimizes outcomes through an alignment of practice, education, research, and leadership. The program offers a number of opportunities for intern exploration that may include pharmacy technician activities, pharmacist shadowing in a variety of clinics, medication reconciliation and patient counseling, active learning, literature reviews, leadership and mentorship opportunities, and ownership and completion of patient- related and/or quality improvement projects in collaboration with CPP’s in their respective clinics. Interns will also have the opportunity to practice good communication skills through patient interactions as well as discussions and presentations with pharmacists, residents, and other health care professionals. PROGRAM FORMAT The internship encompasses a concentrated experience during the summer that continues throughout the academic year. Students completing the program should expect to gain an understanding of clinical programs and operations within the UNC Medical Center Specialty and Primary Clinic (SCP) team practice sites that often include a specialty pharmacy component.
    [Show full text]
  • Study Guide Medical Terminology by Thea Liza Batan About the Author
    Study Guide Medical Terminology By Thea Liza Batan About the Author Thea Liza Batan earned a Master of Science in Nursing Administration in 2007 from Xavier University in Cincinnati, Ohio. She has worked as a staff nurse, nurse instructor, and level department head. She currently works as a simulation coordinator and a free- lance writer specializing in nursing and healthcare. All terms mentioned in this text that are known to be trademarks or service marks have been appropriately capitalized. Use of a term in this text shouldn’t be regarded as affecting the validity of any trademark or service mark. Copyright © 2017 by Penn Foster, Inc. All rights reserved. No part of the material protected by this copyright may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without permission in writing from the copyright owner. Requests for permission to make copies of any part of the work should be mailed to Copyright Permissions, Penn Foster, 925 Oak Street, Scranton, Pennsylvania 18515. Printed in the United States of America CONTENTS INSTRUCTIONS 1 READING ASSIGNMENTS 3 LESSON 1: THE FUNDAMENTALS OF MEDICAL TERMINOLOGY 5 LESSON 2: DIAGNOSIS, INTERVENTION, AND HUMAN BODY TERMS 28 LESSON 3: MUSCULOSKELETAL, CIRCULATORY, AND RESPIRATORY SYSTEM TERMS 44 LESSON 4: DIGESTIVE, URINARY, AND REPRODUCTIVE SYSTEM TERMS 69 LESSON 5: INTEGUMENTARY, NERVOUS, AND ENDOCRINE S YSTEM TERMS 96 SELF-CHECK ANSWERS 134 © PENN FOSTER, INC. 2017 MEDICAL TERMINOLOGY PAGE III Contents INSTRUCTIONS INTRODUCTION Welcome to your course on medical terminology. You’re taking this course because you’re most likely interested in pursuing a health and science career, which entails ­proficiency­in­communicating­with­healthcare­professionals­such­as­physicians,­nurses,­ or dentists.
    [Show full text]
  • Frater, Robert
    Oral History Interview with Robert Frater Cardiothoracic Surgeon St. Jude’s Medical Center FDA Oral History Program Final Edited Transcript May 2003 Table of Contents Oral History Abstract ...................................................................................................................... 2 Keywords ........................................................................................................................................ 2 Citation Instructions ........................................................................................................................ 2 Interviewer Biography ..................................................................................................................... 3 FDA Oral History Program Mission Statement .............................................................................. 3 Statement on Editing Practices ....................................................................................................... 3 Index ............................................................................................................................................... 4 Interview Transcript ........................................................................................................................ 5 Robert Frater Oral History 1 Oral History Abstract This interview was conducted in an effort to collect background information on the development of cardiothoracic surgery and heart valve design and surgical implantation. Dr. Frater was a pioneer in the development
    [Show full text]
  • 1724 Penetration of Therapeutic Aerosols (Ta
    PULMONOLOGY INCREASED VENTILATORY DRIVE AND IMPROVED LOAD COMPEN- PROGRESSION OF CYSTIC FIBROSIS LUNG DISEASE IS DE- SATION WITH CAFFEINE THERAPY. S. Abbasi, E.M. Sivieri, CREASED BY PREDNISONE IN A 4 YEAR CONTROLLED TRIAL. 1723 T.H. Shaffer, W.W. Fox. Univ. Pa. Sch. Med., Dept. H. Auerbach, M. Williams, H.R. Colten. Harvard Pediatrics, Pennsylvania Hospital, Temple Univ. Sch. Med., Dept. Medical School, Boston, Ma. 02115 of Physiology, children's Hospital of Philadelphia, Pa. A randomized double-blinded study was initiated to examine To evaluate the effect of caffeine therapy (CT) on ventilatory the effects of the anti-inflammatory agent, prednisone, on the response of growing preterm infants to a combined inspiratory and progression of lung disease in CF. A total of 43 patients with expiratory resistive load (R), 6 infants were studied before and CF were given either 2 mg/kg prednisone every other day, or pla- during CT. Mean ? SEM, BW=1730+58gm, GA=32.7+0.8 wks, study age cebo. At the onset of the study, patients were between one and =22.3+4.9 wks, study weight=2231+132gm, CT level=10.0+1.3 mgtdl. 12 years of age and were minimally affected as judged by pulmo- These infants had no lung disease at birth. Pulmonary mechanics nary function studies, chest x-ray scores, and serological para- (dynamic lung compliance, inspiratory and expiratory resistance, meters. The two groups did not statistically differ (Mann- and total pulmonary resistance) were normal at the time of study. Whitney analysis) according to all values measured. After 4
    [Show full text]
  • Case Report Vocal Cord Dysfunction: a Frequently Forgotten Entity
    Hindawi Publishing Corporation Case Reports in Pulmonology Volume 2012, Article ID 525493, 4 pages doi:10.1155/2012/525493 Case Report Vocal Cord Dysfunction: A Frequently Forgotten Entity S. Campainha, C. Ribeiro, M. Guimaraes,˜ and R. Lima Pulmonology Department, Centro Hospitalar de Vila Nova de Gaia/Espinho EPE, 4434-502 Vila Nova De Gaia, Portugal Correspondence should be addressed to S. Campainha, [email protected] Received 4 June 2012; Accepted 16 August 2012 Academic Editors: C. S. King, H. Niwa, K. M. Nugent, and W. Rodriguez Copyright © 2012 S. Campainha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Vocal cord dysfunction (VCD) is a disorder characterized by unintentional paradoxical adduction of the vocal cords, resulting in episodic shortness of breath, wheezing and stridor. Due to its clinical presentation, this entity is frequently mistaken for asthma. The diagnosis of VCD is made by direct observation of the upper airway by rhinolaryngoscopy, but due to the variable nature of this disorder the diagnosis can sometimes be challenging. We report the case of a 41-year old female referred to our Allergology clinics with the diagnosis of asthma. Thorough investigation revealed VCD as the cause of symptoms. 1. Introduction to inhaled therapy with formoterol/budesonide 320/9 µgbid and on a rescue basis. Vocal cord dysfunction (VCD) is a disorder characterized by She had a past medical history of snoring (OSAS was for- episodic unintentional paradoxical adduction of the vocal mally excluded by polysomnography), obesity, and hemithy- cords, primarily on inspiration, inducing paroxysms of glot- roidectomy 15 years prior due to a colloid nodule.
    [Show full text]
  • 2 Year Old Boy with Failure to Thrive ATS 2017
    2 year old boy with failure to thrive ATS 2017 Presenter: Discussant: Apeksha Sathyaprasad, MD Folasade O. Ogunlesi, MD Pediatric Pulmonary Fellow Assistant Professor of Pediatrics St. Louis Children’s Hospital/ Washington University in Children's National Medical Center/ The George St. Louis Washington University School of Medicine & Health Sciences History of Present Illness 2 year old African-American male admitted for septic shock, multiorgan dysfunction syndrome due to central line associated candidemia Initially presented to pediatrician’s office in respiratory distress and ultimately admitted to the PICU • Respiratory failure- intubated and on mechanical ventilatory support • Septic shock- vasopressors • Renal failure- continuous veno-venous hemofiltration Pulmonology consulted on hospital day #10 because of prolonged mechanical ventilatory support Pediatric Pulmonology Past Medical History Born full-term, birth weight 3.318 Kg. Pregnancy, delivery, newborn period was unremarkable. Did not require oxygen support, no history of delayed passage of meconium. No history of chronic persistent rhinitis or cough 1 year of age- chronic diarrhea and poor weight gain • Endoscopy, contrast imaging, hepatic enzymes, anti-tTG: unremarkable • Dietary modifications (higher calorie elemental formula) • G-tube with Nissen fundoplication • Chronic intravenous hyperalimentation Central line-associated blood stream infection • S. viridans, Klebsiella, E.coli, Enterococcus, S. aureus History of eczema, intermittent cough and wheezing with viral illnesses which reportedly responded to treatment with inhaled albuterol Pediatric Pulmonology Family and social history Family History: Grandmother has recurrent sinusitis. No history of asthma, cystic fibrosis, recurrent infections, infertility, gastrointestinal diseases Social history: Lives with mother and grandmother. Does not attend daycare. No second-hand tobacco exposure. No avian or agricultural exposures.
    [Show full text]
  • Pediatric Pulmonology
    Received: 14 February 2020 | Accepted: 26 February 2020 DOI: 10.1002/ppul.24718 ORIGINAL ARTICLE: INFECTION AND IMMUNITY Clinical and CT features in pediatric patients with COVID‐19 infection: Different points from adults Wei Xia MD1 | Jianbo Shao MD1 | Yu Guo MD1 | Xuehua Peng MD1 | Zhen Li MD2 | Daoyu Hu MD2 1Department of Imaging Center, Wuhan Children's Hospital (Wuhan Maternal and Abstract Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Purpose: To discuss the different characteristics of clinical, laboratory, and chest Technology, Wuhan, Hubei, China computed tomography (CT) in pediatric patients from adults with 2019 novel cor- 2Department of Radiology, Tongji Hospital, onavirus (COVID‐19) infection. Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, Methods: The clinical, laboratory, and chest CT features of 20 pediatric inpatients China with COVID‐19 infection confirmed by pharyngeal swab COVID‐19 nucleic acid test Correspondence were retrospectively analyzed during 23 January and 8 February 2020. The clinical Jianbo Shao, MD, Department of Imaging and laboratory information was obtained from inpatient records. All the patients Center, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), were undergone chest CT in our hospital. Tongji Medical College, Huazhong University Results: Thirteen pediatric patients (13/20, 65%) had an identified history of close of Science and Technology, Wuhan, 430015 Hubei, China. contact with COVID‐19 diagnosed family members. Fever (12/20, 60%) and cough Email: [email protected] (13/20, 65%) were the most common symptoms. For laboratory findings, procalci- tonin elevation (16/20, 80%) should be pay attention to, which is not common in adults.
    [Show full text]
  • Pulmonary Medicine More Than 100 Online Resources in Pulmonary Medicine
    Pulmonary Medicine More than 100 Online Resources in Pulmonary Medicine According to the World Health Organization, more than 235 million people worldwide suffer from asthma and 64 million struggle with chronic obstructive pulmonary disease (COPD). In fact, 3 million of those afflicted with COPD died in 2005. Healthcare professionals involved with the treatment and care of patients with respiratory diseases clearly need access to the latest research and most effective clinical techniques. Expand your e-resources in Pulmonary Medicine with over Fortunately, Ovid® offers a single, easy-to-use access point for more than 100 full-text and 80 books, 20 full-text journals, bibliographic resources published by some of the world’s leading authorities in medicine 2 bibliographic databases, and a and healthcare. must-have book collection from the American College of Chest This comprehensive content selection is comprised of 81 books, 20 journals, 2 databases, Physicians as well as an ebook collection that’s only available through Ovid. And keep in mind that Ovid makes information searching fast and easy. Whether you’re a pulmonologist in a Access current research on the clinical setting, a researcher, educator, or student, you’ll have the critical information you diagnosis and treatment of need at your fingertips. respiratory diseases, as well as circulation, pulmonary testing and imaging, and other key topic areas Did You Know? Offer premium core resources from You’ll find resources from 15 of the world’s premier scientific and healthcare publishers
    [Show full text]
  • Regarding the SARS Cov-2 Pandemic
    Guidance from the International Society of Heart and Lung Transplantation regarding the SARS CoV-2 pandemic REVISED: August 19, 2020 An international group of ISHLT members representing Infectious Diseases, Pulmonology, Cardiology, Cardiothoracic Surgery and Pharmacy was appointed by the Executive Board of the ISHLT to discuss frequently asked questions related to the current pandemic caused by SARS- CoV-2 (virus) causing the disease coronavirus disease 2019 (COVID-19). The group has met frequently to update this document as more data and experience become available. This guidance is pertinent to care providers of patients with chronic lung/ heart disease and transplant, mechanical circulatory support, and pulmonary vascular disease. NEW INFORMATION IN THIS REVISION: - updated donor and recipient selection for cardiothoracic transplant - lung transplant listing criteria for COVID-19 related acute respiratory distress syndrome CONTRIBUTORS: Chair: Saima Aslam Infectious Diseases: Lara Danziger-Isakov, Me-Linh Luong, Shahid Husain, Fernanda P. Silveira, Paolo Grossi Cardiology: Eric Adler, Marta Farrero, Maria Frigerio, Enrico Ammirati, Luciano Potena, Mandeep R. Mehra, Jeffrey Teuteberg, Raymond Benza Pulmonology: Are Holm, Federica Meloni, Lianne Singer, Erika Lease, Stuart Sweet, Christian Benden, Maria M. Crespo, Marie Budev, Peter Hopkins, Andrew Courtwright Cardiothoracic Surgery: Stephan Ensminger, Jan Gummert, Marcelo Cypel, Daniel Goldstein Pharmacy: Michael Shullo, Patricia Ging 1 INDEX 1. Risk factors and severity of COVID-19 Page 3 2. Reducing risk of infection with SARS-CoV-2 Pages 3-5 3. SARS-CoV-2 testing Page 5-6 4. Management of a patient with chronic lung/heart disease and Pages 6-8 transplant, mechanical circulatory support or pulmonary vascular disease with confirmed COVID-19 5.
    [Show full text]
  • English Medical Terminology – Different Ways of Forming Medical Terms
    JAHR Vol. 4 No. 7 2013 Original scientific article Božena Džuganová* English medical terminology – different ways of forming medical terms ABSTRACT In medical terminology, two completely different phenomena can be seen: 1. precisely worked-out and internationally standardised anatomical nomenclature and 2. quickly devel- oping non-standardised terminologies of individual clinical branches. While in the past new medical terms were mostly formed morphologically by means of derivation and composition from Latin and Greek word-forming components, nowadays it is the syntactic method which prevails – the forming of terminological compounds that subsequently turn into abbrevia- tions. Besides the most frequent ways of term formation, there are also some marginal ways, the results of which are acronyms, backcronyms, eponyms, toponyms, mythonyms etc. To understand the meaning of these rather rare medical terms requires us to become familiar with their etymology and motivation. In our paper we will take a look at individual ways of word-formation with focus on marginal procedures. Keywords: English medical terminology, derivation, composition, compound terms, abbre- viations, acronyms, backronyms, eponyms, toponyms, mythonyms In the last century clinical medicine developed into many new branches. Internal medicine for example started to specialise in cardiology, endocrinology, gastroenter- ology, haematology, infectology, nephrology, oncology, pulmonology, rheumatology etc. All this could happen thanks to the great development of science and technolo- gy. New diagnostic devices and methods were invented, e.g. computer tomography, sonograph, mammograph, laparoscope, endoscope, colonoscope, magnetic reso- * Correspondence address: PhDr. Božena Džuganová, PhD., Comenius University, Jessenius Faculty of Medicine, Department of Foreign Languages, Martin, Slovakia, e-mail: [email protected] 55 JAHR Vol.
    [Show full text]
  • Variability in Anesthesia Models of Care in Cardiac Surgery
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 25 November 2020 doi:10.20944/preprints202010.0085.v2 Communication Variability in Anesthesia Models of Care In Cardiac Surgery Dianne McCallister 1, Bethany Malone 2 , Jennifer Hanna3, and Michael S Firstenberg 3,* 1 Diagnosis Well, Inc, Greenwood Village, Colorado, USA; [email protected]. 2 Department of Surgery, Summa Akron City Hospital, Akron, Ohio, USA; [email protected]. 3 Department of Cardiothoracic and Vascular Surgery, The Medical Center of Aurora, Aurora, Colorado, USA; [email protected]. * Correspondence: [email protected] Abstract: The operating room in a cardiothoracic surgical case is a complex environment, with multiple handoffs often required by staffing changes, and can be variable from program to program. This study was done to characterize what types of practitioners provide anesthesia during cardiac operations to determine the variability in this aspect of care. A survey was sent out via a list serve of members of the cardiac surgical team. Responses from 40 programs from a variety of countries showed variability across every dimension requested of the cardiac anesthesia team. Given that anesthesia is proven to have influence on the outcome of cardiac procedures, this study indicates the opportunity to further study how this variability influences outcomes, and to identify best practices. Keywords: Cardiothoracic Surgery; Anesthesia Staffing Models; Outcomes; Operating Room Staffing; Handoffs; Quality; Communication 1. Introduction The operating room is a complex environment, with multiple team members, many of whom may move on and off the team based on shifts and other factors. The use of handoffs is a common procedure that can be employed to try to create continuity of care.
    [Show full text]